Nomifensine in parkinsonism
- PMID: 796415
- PMCID: PMC492568
- DOI: 10.1136/jnnp.39.12.1219
Nomifensine in parkinsonism
Abstract
Nomifensine, a tetrahydroisoquinolone antidepressant which facilitates dopaminergic and noradrenergic transmission, was studied in 28 Parkinsonism patients most of whom were also receiving conventional medications. Double-blind evaluations revealed a moderate therapeutic action at a mean dose level of 150 mg daily. Adverse reactions were encountered, similar to those identical by levodopa.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources